Sample | Title | Value | Rank |
GSM1256964 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 1 | 35.3092 | 67 |
GSM1256965 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 2 | 45.8359 | 70 |
GSM1256966 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 3 | 79.859 | 76 |
GSM1256967 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 4 | 118.283 | 79 |
GSM1256980 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 54 before YFV | 187.756 | 84 |
GSM1256984 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 54 seven days after YFV | 77.8251 | 75 |
GSM1256981 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 55 before YFV | 73.6769 | 74 |
GSM1256985 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 55 seven days after YFV | 178.344 | 84 |
GSM1256982 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 56 before YFV | 121.807 | 79 |
GSM1256986 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 56 seven days after YFV | 128.888 | 80 |
GSM1256983 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 57 before YFV | 56.0711 | 71 |
GSM1256987 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 57 seven days after YFV | 134.973 | 81 |